Glutathione-S-transferase pi expression in toxic epidermal necrolysis: A marker of putative oxidative stress in keratinocytes

Skin Pharmacology and Physiology

Volumn 20, Issue 2, 2007, Pages 66-70

  Paquet, P ^a,b   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Glutathione S transferase; Toxic epidermal necrolysis

Indexed keywords

GLUTATHIONE TRANSFERASE P1;

ADULT; AGED; ARTICLE; BULLOUS PEMPHIGOID; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN MANIFESTATION; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEMPHIGOID, BULLOUS;

EID: 33847779077     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097652     Document Type: Article

References (25)

1. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern R, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locate F: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-1607.
2. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986;105:179-184.
3. Pirmohamed M, Graham A, Roberts P, Smith D, Chadwick D, Breckenridge AM, Park BK: Carbamazepine hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. Br J Clin Pharmacol 1991;32:741-749.
4. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau J, Bagot M: Metabolic predisposition to cutaneous adverse drug reactions. Arch Dermatol 1995;131:544-551.
5. Wolkenstein P, Tan C, Lecoeur S, Wechsler J, Garcia-Martin N, Charue D, Bagot M, Beaune P: Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin. Chem Biol Interact 1998;113:39-50.
6. Reilly TP, Lash L, Doll MA, Hein DW, Woster PM, Svensson CK: A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 2000;114:1164-1173.
7. Baron JM, Merk HF: Drug metabolism in the skin. Curr Opin Allergy Clin Immunol 2001;1:287-291.
8. Eaton DL, Barninler TK: Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 1999;49:156-164.
9. Blacker KL, Olsen E, Vessey DA, Bayer TD: Characterization of gluthatione S-transferase in cultured human keratinocytes. J Invest Dermatol 1991;97:442-446.
10. Moral A, Palou J, Lafuente A, Molina R, Pivlacks J, Castel T, Trias M, MMM Group: Immunohistochemical study of alpha, mu and pi class glutathione S-transferase expression in malignant melanoma. Br J Dermatol 1997;136:345-350.
11. Hayes J, McLellan L: Glutathione and glutathione-dependent enzymes represent a coordinately regulated defence against oxidative stress. Free Radic Res 1999;31:273-300.
12. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993;129:92-96.
13. Hayes PC, Bouchier IAD, Beckett GJ: Glutathione S-transferase in humans in health and disease. Gut 1991;32:813-818.
14. Quinn A, Brown K, Bonish BK, Curry J, Gordon KB, Sinacore J, Ganelli R, Nickoloff BJ: Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch Dermatol 2005;141:683-687.
15. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE: Macrophages and tumor necrosis factor-alpha in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-608.
16. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-493.
17. Paquet P, Jacob E, Pirson J, Piérard GE: Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association. Int J Mol Med 2005;16:29-33.
18. Adler V, Yin Z, Fuchs SY, Benezra M, Rosario L, Tew KD, Pinus MR, Sardana M, Henderson CJ, Wolf R, Davis RJ, Ronai L: Regulation of JNK signalling by GSTp. EMBO J 1999;18:1321-1334.
19. Townsend D, Tew KD: The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369-7375.
20. Hayes JD, Pulford D: The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
21. Talalay P, De Lang M, Prochaska HJ: Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA 1988;85:8261-8265.
22. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV. EMBO J 1991;10:2247-2258.
23. Shen H, Tamai K, Satoh K, Hatayama I, Tsuchida S, Sato K: Modulation of class pi glutathione transferase activity by sulphydryl group modification. Arch Biochem Biophys 1991;286:178-182.
24. Ketterer B: A bird's eye view of the glutathione transferase field. Chem Biol Interact 2001;138:27-42.
25. Paquet P, Piérard GE: Keratinocyte injury in drug-induced toxic epidermal necrolysis: simultaneous but distinct topographic expression of CD95R and calprotectin. Int J Mol Med 2002;10:145-147.